MedTrace Logo

Performance of the Acoustic Based CADScor System in Coronary Artery Disease

NCT06655779 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-10-23

No results posted yet for this study

Summary

The purpose of this study is to determine if the CAD Score, collected from the CADscore system, performs as well as the Coronary CTA in determining Coronary Artery Disease, in low to intermediate risk patients that are referred for coronary CTA.

Conditions

Interventions

DIAGNOSTIC_TEST

Acoustic Detection of Blood Flow

Subject will have the acoustic device scoring performed prior to a Coronary CTA. No treatment decisions will be based upon the acoustic device score.

Sponsors & Collaborators

  • INTEGRIS Baptist Medical Center

    lead OTHER

Principal Investigators

  • Jon P Blaschke, MD · INTEGRIS Baptist Medical Center

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-30
Primary Completion
2025-12-31
Completion
2026-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06655779 on ClinicalTrials.gov